PT  - JOURNAL ARTICLE
AU  - Butterman, Eric
ED  - Bucaneve, Giampaolo
TI  - Tigecycline plus Standard Therapy is More Effective than Standard Therapy Alone for Treating Infections in Febrile Neutropenic Cancer Patients
DP  - 2011 Dec 01
TA  - MD Conference Express
PG  - 11--12
VI  - 11
IP  - 12
4099  - http://mdc.sagepub.com/content/11/12/11.short
4100  - http://mdc.sagepub.com/content/11/12/11.full
AB  - Tigecycline, first in a new class of glycylcyclines, in combination with piperacillin/tazobactam, is effective, safe, and well tolerated in high-risk febrile neutropenic oncohematologic patients. This combination therapy may aid in reducing the increase and extensive use of carbapenems, which have been associated with an increase in multidrug-resistant bacteria.